Skip to main content

Technological Challenges in Antibiotic Discovery and Development A Workshop Summary (2014) / Chapter Skim
Currently Skimming:

Appendix B: Agenda
Pages 27-28

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 27...
... Appendix B Agenda Technological Challenges in Antibiotic Discovery and Development A Workshop by the Chemical Sciences Roundtable September 23, 2013 -- Washington, DC 8:00 – 8:15 Introduction to Workshop and Topic Session 1:  Overview Chair: Carole Bewley, CSR Member 8:15 – 9:15 Resistance is Futile: A View from the AR Battlefield Rosemary Aurigemma, Section Chief, Drug Development, NIAID, NIH 9:15 – 9:45 Break Session 2: Challenges in Overcoming Antibiotic Resistance Chair: Ken Moloy, CSR Member 9:45 – 10:30 Selecting Antibacterial Targets to avoid Resistance Selection Lynn Silver, Consultant, formerly with Merck 10:30 – 11:15 The Complex Resistance Machineries for β-Lactam Antibiotics in Gram Negative and Gram-Positive Bacteria Shahriar Mobashery, Department of Chemistry and Biochemistry, University of Notre Dame 11:15 – 11:45 Discussion with Speakers 11:45 – 12:45 Lunch Session 3: Challenges in Screening Chair: John Kozarich, CSR Member 12:45 – 1:30 Challenges in Discovering New Antibiotics Through Screening Karen Shaw, Sr. Vice President, Biology, Trius Therapeutics 27
Read the entire page →
From page 28...
... 28 APPENDIX B 1:30 – 2:15 New Ways of Looking at Old Antibiotics and Their Targets Chaitan Khosla, Department of Chemical Engineering, Stanford University 2:15 – 2:45 Discussion with Speakers 2:45 – 3:15 Break Session 4: Challenges in Drug Delivery Chair: Luis Martinez, CSR Member 3:15 – 4:00 Novel Approaches to Antimicrobial Therapeutic Design: A Story of Cocktails and In Vivo Nanomachines  Ruben Morones-Ramírez, Enbiotix and Universidad Autónoma de Nuevo J León 4:00 – 4:45 Overcoming Antibiotic Challenges in Biofilm-Associated Infection Mark Smeltzer, University of Arkansas Medical Center 4:45 – 5:15 Discussion with Speakers Closing Discussion: The Path Forward Chair: John Kozarich, CSR Member 5:15 – 6:00 Overall panel discussion with all speakers 6:00 Workshop Adjourns
Read the entire page →

Key Terms



This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.